The Cicada Vaccine Forecasting Engine and Guide
0.1.0 - ci-build
The Cicada Vaccine Forecasting Engine and Guide - Local Development build (v0.1.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
Profile: Cicada Immunization Recommendation
date: 2015-04-30 00:00:00-0400
recommendation
Engine and Supporting Data Version
- engine: cicada/0.0.1
- supportingData: CDSi 4.65-508
Doses Remaining: 1
Series Group: Increased Risk
Antigen Needing a Dose: Mumps
Antigen Needing a Dose: Measles
Antigen Needing a Dose: Rubella
Contributing Series Detail
- seriesName: Mumps risk 2-dose series
- seriesGroupName: Increased Risk
- seriesType: risk
- status: Not Complete
- targetDoseNumber: 1
- earliestDate: 2015-05-28 00:00:00-0400
- recommendedDate: 2015-05-28 00:00:00-0400
- pastDueDate: 2015-05-28 00:00:00-0400
- earliestRecommendedIntervalDate: 2015-05-28 00:00:00-0400
Contributing Series Detail
- seriesName: Measles risk 2-dose series
- seriesGroupName: Increased Risk
- seriesType: risk
- status: Not Complete
- targetDoseNumber: 1
- earliestDate: 2015-05-28 00:00:00-0400
- recommendedDate: 2015-05-28 00:00:00-0400
- pastDueDate: 2015-05-28 00:00:00-0400
- earliestRecommendedIntervalDate: 2015-05-28 00:00:00-0400
Contributing Series Detail
- seriesName: Rubella risk 2-dose series
- seriesGroupName: Increased Risk
- seriesType: risk
- status: Not Complete
- targetDoseNumber: 1
- earliestDate: 2015-05-28 00:00:00-0400
- recommendedDate: 2015-05-28 00:00:00-0400
- pastDueDate: 2015-05-28 00:00:00-0400
- earliestRecommendedIntervalDate: 2015-05-28 00:00:00-0400
Vaccine Recommendation Category
- series: Mumps risk 2-dose series
- category: High-Risk
- material: https://www.cdc.gov/mumps/hcp/vaccine-considerations/index.html
Vaccine Recommendation Category
- series: Measles risk 2-dose series
- category: High-Risk
- material: https://www.cdc.gov/measles/hcp/vaccine-considerations/index.html
Vaccine Recommendation Category
- series: Rubella risk 2-dose series
- category: High-Risk
- material: https://www.cdc.gov/rubella/hcp/vaccine-considerations/index.html
Series Type: Risk
vaccineCode: MMR
targetDisease: MMR
forecastStatus: Not Complete
dateCriterion
code: Earliest date to give
value: 2015-05-28 00:00:00-0400
dateCriterion
code: Date vaccine due
value: 2015-05-28 00:00:00-0400
dateCriterion
code: Date when overdue for immunization
value: 2015-05-28 00:00:00-0400
description: Persons identified as being at increased risk who have received less than or equal to 2 doses of mumps virus-containing vaccine should receive 1 dose. Antigens: Mumps, Measles, Rubella
doseNumber: 2
supportingPatientInformation: Health care personnel
recommendation
Engine and Supporting Data Version
- engine: cicada/0.0.1
- supportingData: CDSi 4.65-508
Doses Remaining: 1
Series Group: Standard
Contributing Series Detail
- seriesName: Mumps 2-dose series
- seriesGroupName: Standard
- seriesType: standard
- status: Complete
- targetDoseNumber: 2
Contributing Series Detail
- seriesName: Measles 2-dose series
- seriesGroupName: Standard
- seriesType: standard
- status: Complete
- targetDoseNumber: 2
Contributing Series Detail
- seriesName: Rubella 2-dose series
- seriesGroupName: Standard
- seriesType: standard
- status: Complete
- targetDoseNumber: 2
Series Type: Standard
vaccineCode: MMR
targetDisease: MMR
forecastStatus: Complete
forecastReason: Patient series is complete
description: Antigens: Mumps, Measles, Rubella
recommendation
Engine and Supporting Data Version
- engine: cicada/0.0.1
- supportingData: CDSi 4.65-508
Doses Remaining: Recurring
Series Group: Standard
Antigen Needing a Dose: Pertussis
Antigen Needing a Dose: Tetanus
Antigen Needing a Dose: Diphtheria
Contributing Series Detail
- seriesName: Pertussis standard series
- seriesGroupName: Standard
- seriesType: standard
- status: Not Complete
- targetDoseNumber: 6
- earliestDate: 1962-08-12 00:00:00-0400
- recommendedDate: 1962-08-12 00:00:00-0400
- pastDueDate: 1962-08-12 00:00:00-0400
- minimumAgeDate: 1962-08-12 00:00:00-0400
- earliestRecommendedAgeDate: 1962-08-12 00:00:00-0400
- latestRecommendedAgeDate: 1962-08-12 00:00:00-0400
Contributing Series Detail
- seriesName: Tetanus standard series
- seriesGroupName: Standard
- seriesType: standard
- status: Not Complete
- targetDoseNumber: 6
- earliestDate: 1962-08-12 00:00:00-0400
- recommendedDate: 1962-08-12 00:00:00-0400
- pastDueDate: 1962-08-12 00:00:00-0400
- minimumAgeDate: 1962-08-12 00:00:00-0400
- earliestRecommendedAgeDate: 1962-08-12 00:00:00-0400
- latestRecommendedAgeDate: 1962-08-12 00:00:00-0400
Contributing Series Detail
- seriesName: Diphtheria standard series
- seriesGroupName: Standard
- seriesType: standard
- status: Not Complete
- targetDoseNumber: 6
- earliestDate: 1962-08-12 00:00:00-0400
- recommendedDate: 1962-08-12 00:00:00-0400
- pastDueDate: 1962-08-12 00:00:00-0400
- minimumAgeDate: 1962-08-12 00:00:00-0400
- earliestRecommendedAgeDate: 1962-08-12 00:00:00-0400
- latestRecommendedAgeDate: 1962-08-12 00:00:00-0400
Vaccine Recommendation Category
- series: Pertussis standard series
- category: Routine
- material: https://www.cdc.gov/pertussis/hcp/vaccine-recommendations/index.html
Vaccine Recommendation Category
- series: Tetanus standard series
- category: Routine
- material: https://www.cdc.gov/tetanus/hcp/vaccine-recommendations/index.html
Vaccine Recommendation Category
- series: Diphtheria standard series
- category: Routine
- material: https://www.cdc.gov/diphtheria/hcp/vaccine-recommendations/index.html
Series Type: Standard
vaccineCode: DTaP, unspecified formulation
targetDisease: DTaP/Tdap/Td
forecastStatus: Not Complete
dateCriterion
code: Earliest date to give
value: 1962-08-12 00:00:00-0400
dateCriterion
code: Date vaccine due
value: 1962-08-12 00:00:00-0400
dateCriterion
code: Date when overdue for immunization
value: 1962-08-12 00:00:00-0400
description: Dose 4 may be administered as early as age 12 months if at least 6 months have elapsed since dose 3 Antigens: Pertussis, Tetanus, Diphtheria
doseNumber: 1
recommendation
Engine and Supporting Data Version
- engine: cicada/0.0.1
- supportingData: CDSi 4.65-508
Doses Remaining: Recurring
Series Group: Standard
Antigen Needing a Dose: Influenza
Contributing Series Detail
- seriesName: Influenza standard series
- seriesGroupName: Standard
- seriesType: standard
- status: Not Complete
- targetDoseNumber: 1
- earliestDate: 2025-07-01 00:00:00-0400
- recommendedDate: 2025-07-01 00:00:00-0400
- pastDueDate: 2025-07-01 00:00:00-0400
- seasonalRecommendationStartDate: 2025-07-01 00:00:00-0400
Vaccine Recommendation Category
- series: Influenza standard series
- category: Routine
- material: https://www.cdc.gov/flu/hcp/vax-summary/index.html
Series Type: Standard
vaccineCode: influenza, unspecified formulation
targetDisease: Influenza
forecastStatus: Not Complete
dateCriterion
code: Earliest date to give
value: 2025-07-01 00:00:00-0400
dateCriterion
code: Date vaccine due
value: 2025-07-01 00:00:00-0400
dateCriterion
code: Date when overdue for immunization
value: 2025-07-01 00:00:00-0400
description: ACIP recommends persons aged 65 years and older preferentially receive any one of the following higher dose or adjuvanted influenza vaccines: trivalent high-dose inactivated influenza vaccine (HD-IIV3), trivalent recombinant influenza vaccine (RIV3), or trivalent adjuvanted inactivated influenza vaccine (aIIV3). If none of these three vaccines is available at an opportunity for vaccine administration, then any other age-appropriate influenza vaccine should be used. All persons aged 6 months and older with egg allergy should receive influenza vaccine. Any influenza vaccine (egg based or non-egg based) that is otherwise appropriate for the recipient's age and health status can be used. Solid organ transplant recipients aged 19 through 64 years receiving immunosuppressive medications can receive HD-IIV3 or aIIV3. No preference over other age-appropriate IIV3 or RIV3 vaccines. For most people who need only one dose of influenza vaccine for the season, September and October are generally good times to be vaccinated against influenza. Ideally, everyone should be vaccinated by the end of October.
series: Influenza standard series
doseNumber: 1
recommendation
Engine and Supporting Data Version
- engine: cicada/0.0.1
- supportingData: CDSi 4.65-508
Contributing Series Detail
- seriesName: Hib start at 2 months 4-dose series
- seriesGroupName: Standard
- seriesType: standard
- status: Aged Out
Series Type: Standard
vaccineCode: Hib, unspecified formulation
targetDisease: Hib
forecastStatus: Aged Out
forecastReason: Patient has exceeded the maximum age
recommendation
Engine and Supporting Data Version
- engine: cicada/0.0.1
- supportingData: CDSi 4.65-508
Doses Remaining: 2
Series Group: Standard 50+
Antigen Needing a Dose: Pneumococcal
Contributing Series Detail
- seriesName: Pneumococcal 50+ 1-dose PCV series
- seriesGroupName: Standard 50+
- seriesType: standard
- status: Not Complete
- earliestDate: 2005-08-12 00:00:00-0400
- recommendedDate: 2005-08-12 00:00:00-0400
- pastDueDate: 2005-08-12 00:00:00-0400
- minimumAgeDate: 2005-08-12 00:00:00-0400
- earliestRecommendedAgeDate: 2005-08-12 00:00:00-0400
Vaccine Recommendation Category
- series: Pneumococcal 50+ 1-dose PCV series
- category: Routine
- material: https://www.cdc.gov/pneumococcal/hcp/vaccine-recommendations/index.html#cdc_generic_section_3-adults-50-years-or-older
Series Type: Standard
vaccineCode: Pneumococcal Conjugate, unspecified formulation, PCV15, PCV20, PCV21
targetDisease: Pneumococcal
forecastStatus: Not Complete
dateCriterion
code: Earliest date to give
value: 2005-08-12 00:00:00-0400
dateCriterion
code: Date vaccine due
value: 2005-08-12 00:00:00-0400
dateCriterion
code: Date when overdue for immunization
value: 2005-08-12 00:00:00-0400
description: Adults who have received PCV15 but have not yet completed PPSV23 series, can complete the series with either 1 dose of PCV20 or 1 dose of PCV21 if they no longer have access to PPSV23.
series: Pneumococcal 50+ 1-dose PCV series
doseNumber: 1
recommendation
Engine and Supporting Data Version
- engine: cicada/0.0.1
- supportingData: CDSi 4.65-508
Doses Remaining: 2
Series Group: Standard
Antigen Needing a Dose: Varicella
Contributing Series Detail
- seriesName: Varicella childhood 2-dose series
- seriesGroupName: Standard
- seriesType: standard
- status: Not Complete
- earliestDate: 2015-05-28 00:00:00-0400
- recommendedDate: 2015-05-28 00:00:00-0400
- pastDueDate: 2015-05-28 00:00:00-0400
- minimumAgeDate: 1956-08-12 00:00:00-0400
- earliestRecommendedAgeDate: 1956-08-12 00:00:00-0400
- latestRecommendedAgeDate: 1957-01-09 00:00:00-0500
Vaccine Recommendation Category
- series: Varicella childhood 2-dose series
- category: Routine
- material: https://www.cdc.gov/chickenpox/hcp/vaccine-considerations/index.html
Series Type: Standard
vaccineCode: varicella
targetDisease: Varicella
forecastStatus: Not Complete
dateCriterion
code: Earliest date to give
value: 2015-05-28 00:00:00-0400
dateCriterion
code: Date vaccine due
value: 2015-05-28 00:00:00-0400
dateCriterion
code: Date when overdue for immunization
value: 2015-05-28 00:00:00-0400
description: HIV-infected people eligible for vaccination should get 2 doses of single-antigen varicella vaccine separated by 3 months. HIV-infected people should not get the combination MMRV vaccine.
series: Varicella childhood 2-dose series
doseNumber: 1
recommendation
Engine and Supporting Data Version
- engine: cicada/0.0.1
- supportingData: CDSi 4.65-508
Doses Remaining: 3
Series Group: Standard
Antigen Needing a Dose: HepB
Contributing Series Detail
- seriesName: HepB 3-dose series
- seriesGroupName: Standard
- seriesType: standard
- status: Not Complete
- earliestDate: 1955-08-12 00:00:00-0400
- recommendedDate: 1955-08-12 00:00:00-0400
- pastDueDate: 1955-09-08 00:00:00-0400
- minimumAgeDate: 1955-08-12 00:00:00-0400
- earliestRecommendedAgeDate: 1955-08-12 00:00:00-0400
- latestRecommendedAgeDate: 1955-09-09 00:00:00-0400
Vaccine Recommendation Category
- series: HepB 3-dose series
- category: Routine
- material: https://www.cdc.gov/vaccines/hcp/imz-schedules/child-adolescent-notes.html#note-hepb
Series Type: Standard
vaccineCode: Hep B, unspecified formulation
targetDisease: HepB
forecastStatus: Not Complete
dateCriterion
code: Earliest date to give
value: 1955-08-12 00:00:00-0400
dateCriterion
code: Date vaccine due
value: 1955-08-12 00:00:00-0400
dateCriterion
code: Date when overdue for immunization
value: 1955-09-08 00:00:00-0400
description: Anyone age 60 years or older who does not meet risk-based recommendations may still receive Hepatitis B vaccination.
series: HepB 3-dose series
doseNumber: 1
recommendation
Engine and Supporting Data Version
- engine: cicada/0.0.1
- supportingData: CDSi 4.65-508
Contributing Series Detail
- seriesName: Meningococcal ACWY 2-dose series
- seriesGroupName: Standard
- seriesType: standard
- status: Aged Out
- targetDoseNumber: 1
Series Type: Standard
vaccineCode: meningococcal, unspecified formulation
targetDisease: Meningococcal
forecastStatus: Aged Out
forecastReason: Patient has exceeded the maximum age
recommendation
Engine and Supporting Data Version
- engine: cicada/0.0.1
- supportingData: CDSi 4.65-508
Doses Remaining: Recurring
Series Group: Standard
Antigen Needing a Dose: COVID-19
Contributing Series Detail
- seriesName: COVID-19 start at 6mo-23mo shared clinical decision-making series
- seriesGroupName: Standard
- seriesType: standard
- status: Not Complete
- earliestDate: 2025-08-27 00:00:00-0400
- recommendedDate: 2025-08-27 00:00:00-0400
- pastDueDate: 2025-08-27 00:00:00-0400
- minimumAgeDate: 1956-02-12 00:00:00-0500
- earliestRecommendedAgeDate: 1956-02-12 00:00:00-0500
- seasonalRecommendationStartDate: 2025-08-27 00:00:00-0400
Vaccine Recommendation Category
- series: COVID-19 start at 6mo-23mo shared clinical decision-making series
- category: SCDM
- material: https://www.cdc.gov/covid/hcp/vaccine-considerations/routine-guidance.html
Series Type: Standard
vaccineCode: SARS-COV-2 (COVID-19) vaccine, unspecified
targetDisease: COVID-19
forecastStatus: Not Complete
forecastReason: Recommended by shared clinical decision-making
dateCriterion
code: Earliest date to give
value: 2025-08-27 00:00:00-0400
dateCriterion
code: Date vaccine due
value: 2025-08-27 00:00:00-0400
dateCriterion
code: Date when overdue for immunization
value: 2025-08-27 00:00:00-0400
description: Vaccination based on individual-based decision-making- with an emphasis that the risk-benefit of vaccination is most favorable for individuals who are at an increased risk for severe COVID-19 disease and lowest for individuals who are not at an increased risk according to the CDC list of COVID-19 risk factors. see https://www.cdc.gov/covid/hcp/clinical-care/underlying-conditions.html For people who have a history of myocarditis with MIS-C or MIS-A, see https://www.cdc.gov/covid/hcp/vaccine-considerations/special-situations-and-populations.html#cdc_clinical_guidance_recomm_key-covid-19-vaccination-and-mis-c-and-mis-a
series: COVID-19 start at 6mo-23mo shared clinical decision-making series
doseNumber: 1
recommendation
Engine and Supporting Data Version
- engine: cicada/0.0.1
- supportingData: CDSi 4.65-508
Contributing Series Detail
- seriesName: Polio 4-dose series
- seriesGroupName: Standard
- seriesType: standard
- status: Aged Out
Series Type: Standard
vaccineCode: polio, unspecified formulation
targetDisease: Polio
forecastStatus: Aged Out
forecastReason: Patient has exceeded the maximum age
recommendation
Engine and Supporting Data Version
- engine: cicada/0.0.1
- supportingData: CDSi 4.65-508
Doses Remaining: 2
Series Group: Standard
Antigen Needing a Dose: Zoster
Contributing Series Detail
- seriesName: Zoster 2-dose series
- seriesGroupName: Standard
- seriesType: standard
- status: Not Complete
- earliestDate: 2005-08-12 00:00:00-0400
- recommendedDate: 2005-08-12 00:00:00-0400
- pastDueDate: 2005-08-12 00:00:00-0400
- minimumAgeDate: 2005-08-12 00:00:00-0400
- earliestRecommendedAgeDate: 2005-08-12 00:00:00-0400
Vaccine Recommendation Category
- series: Zoster 2-dose series
- category: Routine
- material: https://www.cdc.gov/shingles/hcp/vaccine-considerations/index.html
Series Type: Standard
vaccineCode: zoster, unspecified formulation
targetDisease: Zoster
forecastStatus: Not Complete
dateCriterion
code: Earliest date to give
value: 2005-08-12 00:00:00-0400
dateCriterion
code: Date vaccine due
value: 2005-08-12 00:00:00-0400
dateCriterion
code: Date when overdue for immunization
value: 2005-08-12 00:00:00-0400
series: Zoster 2-dose series
doseNumber: 1
recommendation
Engine and Supporting Data Version
- engine: cicada/0.0.1
- supportingData: CDSi 4.65-508
Contributing Series Detail
- seriesName: HepA 2-dose series
- seriesGroupName: Standard
- seriesType: standard
- status: Aged Out
Contributing Series Detail
- seriesName: HepA risk Twinrix tertiary 3-dose series
- seriesGroupName: Increased Risk
- seriesType: standard
- status: Not Complete
- earliestDate: 1974-08-12 00:00:00-0400
- recommendedDate: 1974-08-12 00:00:00-0400
- pastDueDate: 1974-08-12 00:00:00-0400
- minimumAgeDate: 1974-08-12 00:00:00-0400
- earliestRecommendedAgeDate: 1974-08-12 00:00:00-0400
Series Type: Standard
vaccineCode: Hep A, unspecified formulation
targetDisease: HepA
forecastStatus: Aged Out
forecastReason: Patient has exceeded the maximum age
recommendation
Engine and Supporting Data Version
- engine: cicada/0.0.1
- supportingData: CDSi 4.65-508
Doses Remaining: 1
Series Group: Standard 75+
Antigen Needing a Dose: RSV
Contributing Series Detail
- seriesName: RSV 75 years+ 1-dose series
- seriesGroupName: Standard 75+
- seriesType: standard
- status: Not Complete
- earliestDate: 2030-08-12 00:00:00-0400
- recommendedDate: 2030-08-12 00:00:00-0400
- pastDueDate: 2030-08-12 00:00:00-0400
- minimumAgeDate: 2030-08-12 00:00:00-0400
- earliestRecommendedAgeDate: 2030-08-12 00:00:00-0400
Vaccine Recommendation Category
- series: RSV 75 years+ 1-dose series
- category: Routine
- material: https://www.cdc.gov/rsv/hcp/vaccine-clinical-guidance/adults.html
Series Type: Standard
vaccineCode: RSV, unspecified
targetDisease: RSV
forecastStatus: Not Complete
dateCriterion
code: Earliest date to give
value: 2030-08-12 00:00:00-0400
dateCriterion
code: Date vaccine due
value: 2030-08-12 00:00:00-0400
dateCriterion
code: Date when overdue for immunization
value: 2030-08-12 00:00:00-0400
series: RSV 75 years+ 1-dose series
doseNumber: 1
recommendation
Engine and Supporting Data Version
- engine: cicada/0.0.1
- supportingData: CDSi 4.65-508
Contributing Series Detail
- seriesName: HPV 2-dose series
- seriesGroupName: Standard
- seriesType: standard
- status: Aged Out
Series Type: Standard
vaccineCode: HPV, unspecified formulation
targetDisease: HPV
forecastStatus: Aged Out
forecastReason: Patient has exceeded the maximum age
recommendation
Engine and Supporting Data Version
- engine: cicada/0.0.1
- supportingData: CDSi 4.65-508
Contributing Series Detail
- seriesName: Meningococcal B 2-dose series MenB-4C Shared Clinical Decision Making
- seriesGroupName: Standard
- seriesType: standard
- status: Aged Out
Series Type: Standard
vaccineCode: meningococcal B, unspecified
targetDisease: Meningococcal B
forecastStatus: Aged Out
forecastReason: Patient has exceeded the maximum age, Recommended by shared clinical decision-making
recommendation
Engine and Supporting Data Version
- engine: cicada/0.0.1
- supportingData: CDSi 4.65-508
Contributing Series Detail
- seriesName: Rotavirus 3-dose series
- seriesGroupName: Standard
- seriesType: standard
- status: Aged Out
Series Type: Standard
vaccineCode: rotavirus, unspecified formulation
targetDisease: Rotavirus
forecastStatus: Aged Out
forecastReason: Patient has exceeded the maximum age